Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-08-28 Sale |
2020-09-01 7:33 pm |
Molecular Templates Inc. | MTEM | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner |
3,496 | $10.75 | $37,568 | 3,202,530 (Indirect) |
View |
| 2020-07-28 Purchase |
2020-07-28 6:20 pm |
Inozyme Pharma Inc. | INZY | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner |
625,000 | $16 | $10,000,000 | 2,819,379 (Indirect) |
View |
| 2020-07-10 Purchase |
2020-07-14 8:11 pm |
89bio Inc. | ETNB | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner |
109,090 | $27.5 | $2,999,975 | 2,600,877 (Indirect) |
View |
| 2020-05-27 Sale |
2020-05-29 7:13 pm |
Aimmune Therapeutics Inc. | AIMT | ENRIGHT PATRICK G Director |
7,840 | $0 | $0 | 6,206,933 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-08-06 Option Award |
2020-08-10 4:42 pm |
N/A 2030-08-05 |
Jazz Pharmaceuticals plc | JAZZ | ENRIGHT PATRICK G Director |
9,470 | $0 | 27,133 (Direct) |
View |
| 2020-07-28 Conversion |
2020-07-28 6:20 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner |
18,592,979 | $0 | 2,819,379 (Indirect) |
View |
Ownership |
2020-07-23 9:26 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner |
0 | $0 | 2,194,379 (Indirect) |
View |
| 2020-06-30 Option Award |
2020-07-02 4:06 pm |
N/A 2030-06-29 |
Aptinyx Inc. | APTX | ENRIGHT PATRICK G Director |
5,436 | $2.677 | 5,436 (Direct) |
View |
Ownership |
2020-06-11 7:56 pm |
N/A N/A |
Vaxcyte Inc. | PCVX | Longitude Capital Partners II LLC Longitude Venture Partners II L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner |
0 | $0 | 3,606,350 (Indirect) |
View |
| 2020-05-27 Option Award |
2020-05-29 7:13 pm |
N/A 2030-05-26 |
Aimmune Therapeutics Inc. | AIMT | ENRIGHT PATRICK G Director |
15,398 | $0 | 6,206,933 (Direct) |
View |
| 2020-05-26 Other |
2020-05-28 9:07 pm |
N/A N/A |
Molecular Templates Inc. | MTEM | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner |
1,006,991 | $0 | 1,008,040 (Indirect) |
View |
| 2020-05-20 Option Award |
2020-05-22 4:10 pm |
N/A 2030-05-19 |
Aptinyx Inc. | APTX | ENRIGHT PATRICK G Director |
40,000 | $0 | 40,000 (Direct) |
View |